VAC14-AS1
geneOn this page
Summary
VAC14-AS1 (VAC14 antisense RNA 1, HGNC:48605) is a long non-coding RNA gene on chromosome 16q22.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48605 |
| Approved symbol | VAC14-AS1 |
| Name | VAC14 antisense RNA 1 |
| Location | 16q22.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000214353 |
| Ensembl biotype | lncRNA |
| Entrez | 100130894 |
| RNAcentral | URS0000D77FC1 — lncRNA, 2192 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000398177, ENST00000562507, ENST00000662383, ENST00000666405
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000398177 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001531958 | 70771608 | 70773242 |
| ENSE00001531961 | 70766443 | 70766556 |
| ENSE00001531962 | 70761153 | 70761258 |
| ENSE00001531964 | 70756013 | 70756087 |
| ENSE00001531966 | 70755035 | 70755249 |
| ENSE00002608776 | 70768846 | 70768943 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 78.44.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4467 / max 54.2742, expressed in 115 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154901 | 0.2615 | 72 |
| 154902 | 0.1145 | 61 |
| 154904 | 0.0506 | 19 |
| 154903 | 0.0202 | 7 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.44 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 72.56 | gold quality |
| nucleus accumbens | UBERON:0001882 | 72.40 | gold quality |
| amygdala | UBERON:0001876 | 72.35 | gold quality |
| hypothalamus | UBERON:0001898 | 71.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.66 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.57 | gold quality |
| caudate nucleus | UBERON:0001873 | 71.09 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 70.90 | gold quality |
| sural nerve | UBERON:0015488 | 70.54 | gold quality |
| cerebellum | UBERON:0002037 | 70.25 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.71 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 69.62 | gold quality |
| bone marrow cell | CL:0002092 | 68.43 | silver quality |
| putamen | UBERON:0001874 | 67.15 | gold quality |
| substantia nigra | UBERON:0002038 | 65.38 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 65.23 | gold quality |
| neocortex | UBERON:0001950 | 63.97 | gold quality |
| medial globus pallidus | UBERON:0002477 | 63.77 | silver quality |
| brain | UBERON:0000955 | 63.72 | gold quality |
| colonic epithelium | UBERON:0000397 | 63.69 | silver quality |
| temporal lobe | UBERON:0001871 | 63.29 | gold quality |
| forebrain | UBERON:0001890 | 63.17 | gold quality |
| midbrain | UBERON:0001891 | 62.97 | gold quality |
| prefrontal cortex | UBERON:0000451 | 62.70 | gold quality |
| frontal cortex | UBERON:0001870 | 62.61 | gold quality |
| cerebral cortex | UBERON:0000956 | 62.50 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 61.99 | silver quality |
| globus pallidus | UBERON:0001875 | 61.94 | silver quality |
| Ammon’s horn | UBERON:0001954 | 61.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.84 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): striatonigral degeneration, childhood-onset